We are live on ! Find out more
NVOS

Novo Integrated Sciences, Inc. Common Stock

Delisted

NVOS was delisted on the 5th of November, 2024.

14 hedge funds and large institutions have $424K invested in Novo Integrated Sciences, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

13% less funds holding

Funds holding: 1614 (-2)

48% less capital invested

Capital invested by funds: $814K → $424K (-$390K)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$142K
Vanguard Group
2
Vanguard Group
Pennsylvania
$122K
Geode Capital Management
3
Geode Capital Management
Massachusetts
$62.3K
VF
4
Virtu Financial
New York
$30K -$16.2K -24,133 -28%
XT
5
XTX Topco
Cayman Islands
$19.4K +$18.4K +27,439 +222%
State Street
6
State Street
Massachusetts
$16.2K
Northern Trust
7
Northern Trust
Illinois
$13.6K
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$8.7K +$12K +17,853 New
TRCT
9
Tower Research Capital (TRC)
New York
$5.38K +$1.38K +2,060 +23%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$4K
Wells Fargo
11
Wells Fargo
California
$59 +$5 +8 +7%
Bank of America
12
Bank of America
North Carolina
$46 -$184 -274 -74%
JP Morgan Chase
13
JP Morgan Chase
New York
$19 +$9 +14 +54%
Morgan Stanley
14
Morgan Stanley
New York
$2 -$3 -5 -50%
Citadel Advisors
15
Citadel Advisors
Florida
-$95.8K -116,659 Closed
Jane Street
16
Jane Street
New York
-$13.2K -16,132 Closed
UBS Group
17
UBS Group
Switzerland
-$9.95K -12,113 Closed

NVOS Hedge Fund Activity: Q1 2024 in Review

14 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q1 2024, worth a combined $424K — down 48% from $814K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NVOS and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 4 added.

The largest buyer was XTX Topco, adding an estimated $18.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $95.8K sold.

  • 14 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q1 2024, down from 16 in Q4 2023.
  • Funds reported $424K of Novo Integrated Sciences, Inc. Common Stock stock for Q1 2024, down 48% quarter-over-quarter.
  • 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q1 2024 and 3 closed out, a net change of -2 holders.
  • The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q1 2024 was XTX Topco, an estimated $18.4K added.
  • The largest Novo Integrated Sciences, Inc. Common Stock seller in Q1 2024 was Citadel Advisors, an estimated $95.8K sold.

Based on aggregated 13F filings for Q1 2024.